- Home
- SMHI vs INZY Comparison
SMHI vs INZY Comparison
Compare SMHI & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- INZY
- Stock Information
- Founded
- SMHI 1989
- INZY 2015
- Country
- SMHI United States
- INZY United States
- Employees
- SMHI N/A
- INZY N/A
- Industry
- SMHI Marine Transportation
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- SMHI Consumer Discretionary
- INZY Health Care
- Exchange
- SMHI Nasdaq
- INZY Nasdaq
- Market Cap
- SMHI 139.9M
- INZY 256.3M
- IPO Year
- SMHI N/A
- INZY 2020
- Fundamental
- Price
- SMHI $5.44
- INZY $4.00
- Analyst Decision
- SMHI
- INZY Buy
- Analyst Count
- SMHI 0
- INZY 9
- Target Price
- SMHI N/A
- INZY $15.22
- AVG Volume (30 Days)
- SMHI 124.3K
- INZY 989.2K
- Earning Date
- SMHI 07-30-2025
- INZY 08-05-2025
- Dividend Yield
- SMHI N/A
- INZY N/A
- EPS Growth
- SMHI N/A
- INZY N/A
- EPS
- SMHI N/A
- INZY N/A
- Revenue
- SMHI $264,089,999.00
- INZY N/A
- Revenue This Year
- SMHI N/A
- INZY N/A
- Revenue Next Year
- SMHI $11.59
- INZY N/A
- P/E Ratio
- SMHI N/A
- INZY N/A
- Revenue Growth
- SMHI N/A
- INZY N/A
- 52 Week Low
- SMHI $3.63
- INZY $0.72
- 52 Week High
- SMHI $15.36
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- SMHI 50.84
- INZY 82.67
- Support Level
- SMHI $4.94
- INZY $3.94
- Resistance Level
- SMHI $5.42
- INZY $3.97
- Average True Range (ATR)
- SMHI 0.30
- INZY 0.01
- MACD
- SMHI -0.08
- INZY -0.08
- Stochastic Oscillator
- SMHI 37.04
- INZY 100.00
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.